According to The Insight Partners market research study titled “Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Diagnosis and Indication ,” the market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5.9% from 2020 to 2028. The report highlights the trends prevailing in the global irritable bowel syndrome (IBS) diagnostics market, along with market drivers and deterrents.

In light of finding, the worldwide touchy gut condition (IBS) diagnostics market is portioned into lab tests and imaging tests. In 2020, the research facility tests section held the biggest offer on the lookout. Additionally, the fragment is supposed to hold the biggest piece of the pie by 2028. The market development is fundamentally credited to the developing predominance of crabby entrail disorder (IBS) around the world, which is probably going to go on before long because of aggravations in gut propensities and stomach torment. This, thus, is supporting the interest for conclusion of these infections around the world.

Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00016657/

Expanding predominance of touchy entrail disorder and related conditions and expanding number of FDA endorsements and diagnostics improvements are driving the worldwide crabby inside disorder (IBS) diagnostics market. Be that as it may, the difficulties in finding of IBS are restricting the market development.

The Coronavirus pandemic is assessed to emphatically affect the peevish entrail disorder (IBS) diagnostics market. Larger part of the drug organizations across the world are participated in the improvement of immunizations for Coronavirus. Additionally, bad tempered entrail disorder (IBS) is habitually set off by Coronavirus stress. Hence, home testing units are desirable over lab testing as research center administrations might be overpowered in the pandemic, which is expected to decidedly affect different portions of the market before long. Be that as it may, disturbances in the production network caused because of the end in worldwide activities are preventing the market development.

A few prominent players operating in the irritable bowel syndrome (IBS) diagnostics market are Commonwealth Diagnostics International; Genova Diagnostics; Gemelli Biotech; Prometheus Laboratories; Inova Diagnostics, Inc.; Biohit Oyj; Aerodiagnostics, LLC.; Metabolic Solutions, Inc.; Sysmex Corporation; and Bühlmann Laboratories AG, among others.

Market players are introducing new and innovative products and services to sustain their position in the irritable bowel syndrome (IBS) diagnostics market. For instance, in February 2020, Commonwealth Diagnostics International (CDI), Inc. announced the commercial re-launch of IBSchek, the first clinically validated biomarker blood test for diarrhea-predominant and mixed-type irritable bowel syndrome (IBS-D, IBS-M) in a new at-home capillary collection kit.

The report segments the global irritable bowel syndrome (IBS) diagnostics market as follows:

 

Irritable Bowel Syndrome (IBS) Diagnostics Market – by Diagnosis

  • Laboratory Tests
    • Lactose Intolerance Tests
    • Breath Test for Bacterial Overgrowth
    • Stool Tests
    • Blood Tests
  • Imaging Tests
    • CT Scan or X-Ray
    • Upper Endoscopy
    • Colonoscopy

 
Irritable Bowel Syndrome (IBS) Diagnostics Market – by Indication

  • Pain and Cramping
  • Diarrhea
  • Constipation
  • Alternating Constipation and Diarrhea


 Irritable Bowel Syndrome (IBS) Diagnostics Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Rest of Middle East & Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

Read More: https://www.theinsightpartners.com/reports/irritable-bowel-syndrome-ibs-diagnostics-market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com